Hester Biosciences Intrinsic Value
Hester Biosciences (HESTERBIO) median intrinsic value is ₹965.93 from 10 valuation models (range ₹659–₹1712), vs current price ₹2195.60 — -56.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Check Hester Biosciences market cap to track the company's total market size over time.
HESTERBIO Valuation Methods Summary — DCF, Graham Number & P/E
Hester Biosciences intrinsic value across 10 models vs current price ₹2195.60 — upside/downside and value range per method. For current market price and key ratios, visit HESTERBIO screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1711.60 | ₹1369.28 - ₹2053.92 | -22.0% | EPS: ₹77.80, Sector P/E: 22x |
| Book Value Method | asset | ₹817.78 | ₹736.00 - ₹899.56 | -62.8% | Book Value/Share: ₹408.89, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹906.67 | ₹816.00 - ₹997.34 | -58.7% | Revenue/Share: ₹453.33, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1600.00 | ₹1440.00 - ₹1760.00 | -27.1% | EBITDA: ₹144.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹965.93 | ₹772.74 - ₹1159.12 | -56.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹658.68 | ₹592.81 - ₹724.55 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1202.01 | ₹1081.81 - ₹1322.21 | -45.3% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1097.80 | ₹988.02 - ₹1207.58 | -50.0% | ROE: 18.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹817.78 | ₹736.00 - ₹899.56 | -62.8% | EPS: ₹77.80, BVPS: ₹408.89 |
| Dividend Yield Method | dividend | ₹658.68 | ₹592.81 - ₹724.55 | -70.0% | DPS: ₹11.00, Target Yield: 2.5% |
HESTERBIO Intrinsic Value vs Market Price — All Valuation Models
Hester Biosciences fair value range ₹659–₹1712 vs current market price ₹2195.60 across 10 valuation models. See HESTERBIO price to book ratio to compare market price against book value per share.
HESTERBIO Intrinsic Value Analysis — Undervalued or Overvalued?
Hester Biosciences median intrinsic value ₹965.93, current price ₹2195.60 — Trading Above Calculated Value by 56.0%, margin of safety -100.0%.
What is the intrinsic value of HESTERBIO?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Hester Biosciences (HESTERBIO) is ₹965.93 (median value). With the current market price of ₹2195.60, this represents a -56.0% variance from our estimated fair value.
The valuation range spans from ₹658.68 to ₹1711.60, indicating ₹658.68 - ₹1711.60.
Is HESTERBIO undervalued or overvalued?
Based on our multi-method analysis, Hester Biosciences (HESTERBIO) appears to be trading above calculated value by approximately 56.0%.
HESTERBIO Financial Health — Key Ratios vs Industry Benchmarks
Hester Biosciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.32 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 18.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 34.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.60x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
HESTERBIO Cash Flow Quality — Operating & Free Cash Flow
Hester Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹64 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹65 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹48 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹24 Cr | ₹-15 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹9 Cr | ₹-50 Cr | Positive Operating Cash Flow | 6/10 |